Experts say any of the three approved subcutaneous injection sites for GLP-1s will work, but users, and some social media ...

Dementia is treated with dementia-specific medication, symptom therapies, cognitive rehabilitation, and lifestyle adjustments ...

Melissa Glassford, DNP, discusses clinical strategies for managing GLP-1 therapy gaps, dose titration, weight plateaus, and ...

The U.S. Food and Drug Administration has granted approval for a new drug targeting the mutations that drive more than 90% of ...

Subcutaneous autoinjector formulation expands starting treatment options for mild cognitive impairment and mild dementia due to Alzheimer disease.

At-home subcutaneous lecanemab may ease the burden of frequent infusions, but clinicians still face key questions about ...

I don’t know if it’s because I’ve been reporting on beauty for over a decade or because I spend a lot of time in Seoul—a ...